Lanean...
CYP1B1 as a therapeutic target in cardio-oncology
Cardiovascular complications have been frequently reported in cancer patients and survivors, mainly because of various cardiotoxic cancer treatments. Despite the known cardiovascular toxic effects of these treatments, they are still clinically used because of their effectiveness as anti-cancer agent...
Gorde:
| Argitaratua izan da: | Clin Sci (Lond) |
|---|---|
| Egile Nagusiak: | , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Portland Press Ltd.
2020
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7672255/ https://ncbi.nlm.nih.gov/pubmed/33185690 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1042/CS20200310 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|